Ozempic Frenzy Lures Rich Indians to Brave the Gray Market
Buyers are clamoring to get drugs like Ozempic and Mounjaro, which are unavailable in India
Ozempic injection pens at the Novo Nordisk production facility in Denmark.
Photographer: Carsten Snejbjerg/BloombergThis article is for subscribers only.
Stashing boxes of injectables in their carry-on luggage. Buying counterfeit formulas online. Importing boxes from Europe. The race to score blockbuster weight-loss drugs is pushing one of the world’s largest population of people with obesity to creative lengths.
Breathless media coverage has helped create a frenzy over the treatments. Such is the interest that the anti-obesity medication market could reach $130 billion by 2030, Goldman Sachs Research said. Indians, meanwhile, have simply been watching this from the sidelines.